Brain-Targeting Emodin Mitigates Ischemic Stroke via Inhibiting AQP4-Mediated Swelling and Neuroinflammation
- 28 June 2023
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 15 (4) , 818-830
Abstract
Failure to achieve target-specific delivery to ischemic brain sites has hampered the clinical efficacy of newly developed therapies for ischemic stroke. EmKeywords
This publication has 43 references indexed in Scilit:
- From blood–brain barrier to blood–brain interface: new opportunities for CNS drug deliveryNature Reviews Drug Discovery, 2016
- Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivoInternational Journal of Nanomedicine, 2015
- The Spectrum of Neurobehavioral Sequelae after Repetitive Mild Traumatic Brain Injury: A Novel Mouse Model of Chronic Traumatic EncephalopathyJournal of Neurotrauma, 2014
- TCM-based new drug discovery and development in ChinaChinese Journal of Natural Medicines, 2014
- Blood–Brain Barrier Na Transporters in Ischemic Stroke2014
- Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor BarrierACS Nano, 2013
- Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid AngiopathyStroke, 2012
- Interleukin‐1β induces the expression of aquaporin‐4 through a nuclear factor‐κB pathway in rat astrocytesJournal of Neurochemistry, 2006
- Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitroNeuropharmacology, 2005
- Acute Focal Ischemia-Induced Alterations in MAP2 Immunostaining: Description of Temporal Changes and Utilization as a Marker for Volumetric Assessment of Acute Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 1996